UNSPSC 51281701: Lenampicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H23N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8M568DM08K, chemically known as 2,3-dihydroxy-2-butenyl(2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, cyclic carbonate but generally known as lenampicillin, which bears US NIH Compound Identifier 65646.

UNSPSC 51281701 Lenampicillin is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities associated with it show little direct activity for lenampicillin itself. Instead, the two tagged opportunities reflect procurement of other pharmaceutical products and medical supplies — antibiotic tablets (doxycycline and ciprofloxacin) and naloxone with drug deactivation systems — suggesting that state and local health agencies use this code tier for pharmaceutical warehouse orders and emergency medical supply contracts more broadly. The issuing bodies are state health departments and county health or emergency services agencies, typically sourcing through piggyback contracts tied to established cooperative purchasing consortia or competitive sealed bidding processes.

Activity appears concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic supply, while Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building. The Seminole County procurement imposed standard compliance requirements including drug-free workplace certification and E-Verify, with a two-year initial term and one-year renewal option. Neither opportunity specified set-aside utilization for disadvantaged or veteran-owned enterprises. The code's recent activity is limited; practitioners should verify whether lenampicillin-specific demand exists in their target jurisdictions or whether this code functions primarily as a catch-all for related pharmaceutical procurements at the state and local level.